Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 20 (10) , 1311-1318
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the OthersJNCI: Journal of the National Cancer Institute, 2016
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA TrialClinical Oncology, 2013
- Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2012
- Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)The Lancet Oncology, 2012
- Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast CancerJNCI: Journal of the National Cancer Institute, 2011
- Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast CancerJournal of Clinical Oncology, 2007
- Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based StudyJournal of Clinical Oncology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast CancerJournal of Clinical Oncology, 2001